Misleading linkage results in an NF2 presymptomatic test owing to mosaicism

Journal of Medical Genetics

Volumn 34, Issue 11, 1997, Pages 934-936

  Bijlsma, E K ^a   Wallace, A J ^b   Evans, D G R ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Linkage analysis; Misleading result; Mosaicism; NF2

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CHROMOSOME 22; CHROMOSOME MOSAICISM; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC ERROR; FEMALE; GENE MUTATION; GENETIC LINKAGE; GENETIC SCREENING; HUMAN; HUMAN CELL; MALE; NEUROFIBROMATOSIS; NONSENSE MUTATION; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0030728563     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.34.11.934     Document Type: Article

References (18)

1. Kanter WR, Eldridge R, Fabricant R, Allen JC, Koerber T. Central neurofibromatosis with bilateral acoustic neuroma: genetic, clinical and biochemical distinctions from peripheral neurofibromatosis. Neurology 1980;30:851-9.
2. Evans DGR, Huson SM, Donnai D, et al. A clinical study of type 2 neurofibromatosis. Q J Med 1992;84:603-18.
3. Parry DM, Eldridge R, Kaiser-Kupfer MI, Bouzas EA, Pikus A, Patronas N. Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity. Am J Med Genet 1994;52:450-1.
4. Seizinger BR, Martuza RL, Gusella JF. Loss of genes on chromosome 22 in tumorigenesis of human acoustic neuroma. Nature 1986;322:644-7.
5. Rouleau G, Wertelecki W, Haines JL, et al. Genetic linkage analysis of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22. Nature 1987;329:246-8.
6. Ruttledge MH, Narod SA, Dumanski JP, et al. Presymptomatic diagnosis for neurofibromatosis 2 with chromosome 22 markers. Neurology 1993;43:1753-60.
7. Rouleau GA, Mérel P, Lutchman M, et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 1993;363: 515-21.
8. Trofatter JA, MacCollin MM, Rutter JL, et al. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 1993;72:791-800.
9. Bourn D, Carter SA, Evans DGR, Goodship J, Coakham H, Strachan T. A mutation in the neurofibromatosis type 2 tumor-suppressor gene, giving rise to widely different clinical phenotypes in two unrelated individuals. Am J Hum Genet 1994;55:69-73.
10. Mérel P, Hoang-Xuan K, Sanson M, et al. Screening for germline mutations in the NF2 gene. Genes Chrom Cancer 1995;12:117-27.
11. Evans DGR, Bourne D, Wallace A, Ramsden RT, Mitchell JD, Strachan T. Diagnostic issues in a family with late onset type 2 neurofibromatosis. J Med Genet 1995;32:470-4.
12. Bourn D, Strachan T. Highly polymorphic dinucleotide repeat at the NF2 gene. Hum Genet 1995;95:712.
13. Weissenbach J, Gyapay G, Dib C, et al. A second generation map of the human genome. Nature 1992;359:794-801.
14. Marineau C, Baron C, Delattre O, et al. Dinucleotide repeat polymorphism at the D22S268 locus. Hum Mol Genet 1993;2:336.
15. Thonney F, Munier F, Balmer A, Heon E, Pescia G, Schorderet DF. Rb1 mutation mosaicism in a retinoblastoma family. Am J Hum Genet 1996;59:A84.
16. Huson SM. Neurofibromatosis 1: a clinical and genetic overview. In: Huson SM, Hughes RAC, eds. The neurofibromatoses: a pathogenetic and clinical overview. Chapter 7. London: Chapman & Hall, 1994:160-203.
17. Gardner WJ, Frazier CH. Bilateral acoustic neurofibromas: a clinical study and field survey of a family of five generations with bilateral deafness in thirty eight members. Arch Neurol Psychiatr 1930;23:266-302.
18. Evans DGR, Huson SM, Donnai D, et al. A genetic study of type 2 neurofibromatosis in the north west of England and the UK. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity. J Med Genet 1992;29:841-6.